Home > Drug Search >
  • company_query: Actover Pharmaceutical
  •   > 
Drug Filter
Category:
chemistry (4) biology (23)
Status:
Approved (5) BLA Filing (1) Phase Ⅲ (3) Phase Ⅱ (9) Phase Ⅰ (8) IND Filing (1)
Clinical Stage:
Active (16) Discontinued (6)
Bio-Type:
Vaccine (12) Recombinant cytokines (5) Whole antibody (1)
Indication:
Acute myeloid Leukemia (AML) (1) Anemia (2) Chronic obstructive pulmonary disease (COPD) (1) Coronary artery disease (CAD) (1) Cystic fibrosis (CF) (1) Uveal melanoma (1) Wet age-related macular degeneration (1) HBV infection (1) HIV infection (2) Inflammatory bowel disease (1) Influenza virus infection (2) Pseudomonal infection (1) Major depressive disorder (MDD) (1) Melanoma (1) Multiple sclerosis (MS) (2) Neuropathic pain (1) Non small cell lung cancer (NSCLC) (1) Osteoarthritis (OA) (1) Pneumonia (1) Measles (1) Mumps (1) Rubella (1) Psoriasis (1) Renal cell carcinoma (1) Rheumatoid arthritis (RA) (1) Systemic lupus erythematosus (1) Tuberculosis (1) Influenza A virus infections (3) Nosocomial Pneumonia (NP) (1) Anesthesia (1) Neutropenia (1) Thrombosis (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top